YouShift vs Uncommon Therapeutics

Side-by-side comparison of AI visibility scores, market position, and capabilities

YouShift leads in AI visibility (35 vs 27)

YouShift

EmergingHealthcare Tech

General

US AI healthcare scheduling agent for hospitals replacing complex manual shift management; Rippling-for-healthcare vision with optimization algorithms and agentic AI targeting nursing staff scheduling competing with Kronos and UKG Workforce.

AI VisibilityBeta
Overall Score
D35
Category Rank
#1159 of 1167
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
35
Perplexity
31
Gemini
36

About

YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the complex, administrator-dependent scheduling software that hospitals currently use. Founded to address the operational inefficiency at the intersection of clinical workforce management and scheduling complexity, YouShift applies optimization algorithms and agentic AI to generate shift schedules that simultaneously respect hospital staffing requirements (coverage ratios, certification requirements, department-specific rules) and staff preferences (requested days off, preferred shift patterns, commute constraints) — eliminating the manual schedule-building work that currently requires full-time administrative staff at most hospital systems.

Full profile

Uncommon Therapeutics

EmergingHealthcare

General

Rare disease biotech developing polytherapy approach for Rett Syndrome (1 in 10,000 girls); founder-developed protocol validated through personal patient experience competing with Acadia Pharmaceuticals Daybue in Rett market.

AI VisibilityBeta
Overall Score
D27
Category Rank
#1121 of 1167
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
28
Perplexity
33
Gemini
36

About

Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1 in 10,000 girls — applying a polytherapy approach (combining multiple therapeutic agents targeting different disease mechanisms simultaneously) to develop treatments for serious neurological and rare diseases. After improving his daughter's quality of life through a personally developed polytherapy protocol, Auerhahn founded Uncommon Therapeutics to translate these insights into pharmaceutical products for the broader Rett Syndrome patient community.

Full profile

AI Visibility Head-to-Head

35
Overall Score
27
#1159
Category Rank
#1121
83
AI Consensus
67
stable
Trend
stable
35
ChatGPT
28
31
Perplexity
33
36
Gemini
36
33
Claude
22
38
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.